Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma: a post hoc analysis of the PATHWAY phase 2b study - Corren, J; Karpefors, M; Hellqvist, Å; Parnes, J R; Colice, G (J Asthma Allergy, 2021)